Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Each week, The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related…
Each week, The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related…
Each week, The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related…
Each week, The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related…
Each week, The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related…
In February of 2015, the New York City Health Business Leaders organization (NYCHBL) held a conference titled “Lean In or Pull Back: Where Will the Healthcare Dollars Flow…
